Industry partnership opportunities
The American Society for Biochemistry and Molecular Biology has teamed up with Halo to provide ASBMB members fresh industry partnership opportunities each month. Below you'll find several requests for assistance from companies seeking certain expertise and technologies. Learn more about our partnership with Halo.
Bayer Pharma: Human stem cells from patients with genetically derived cardiomyopathy
Bayer Crop Science is seeking stem cells from patients with dilated cardiomyopathies (e.g. laminopathy or others). The genetic defect in those patients causing the disease should be known. They would also need certain clinical parameters of those patients. The cells are not intending to be used for clinical research and development. The deadline for this opportunity is May 31. Learn more and apply.
Private company: Unique methods to measure intestinal water and cotransporter regulation
This private company is looking to explore and optimize oral rehydration solutions through the utilization of validated intestinal models. The primary objectives involve evaluating the effects of different solution compositions on intestinal water absorption, solute absorption, and their potential to modulate the activity of co-transporters, particularly those responsible for the transport of sugars and amino acids. The deadline for this opportunity is April 30. Learn more and apply.
BASF: Biodegradable micro-encapsulation of active ingredients
BASF is seeking a biodegradable encapsulation material for hydrophobic active ingredients. Core-shell morphologies are of high interest, but relevant matrix capsules and other morphologies will be considered. The deadline for this opportunity is April 30. Learn more and apply.
Private company: Uncovering the “perfect” natural product from a specific bacteria
This private sponsor is seeking partners who can effectively identify natural project actives derived from a proprietary strain. These identified natural products should demonstrate activity against specific pathogens, while not falling under the categories of antibiotics, siderophores, volatile compounds, unstable polyenes or nonribosomally synthesized peptides. The deadline for this opportunity is April 30. Learn more and apply.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Industry
Industry highlights or most popular articles
A brief history of the performance review
Performance reviews are a widely accepted practice across all industries — including pharma and biotech. Where did the practice come from, and why do companies continue to require them?
The molecular biology of commercial cannabis testing
Anthony Torres of Front Range Biosciences, explains how scientists analyze organisms growing on the plant as well as the genetic markers in cannabis DNA.
For this molecular biologist, cannabis testing is a field of discovery
Anthony Torres went from loving high school biology to working in an industry he’s very enthusiastic about.
Upcoming ASBMB events for future industry scientists — and others
ASBMB offers webinars aimed at a variety of member groups, including scientists who have taken time off for caregiving or members who want to start their own labs. These three will be useful to postdocs and graduate students.
Uncertain Ph.D. path ends with a sprint to an industry job
Serena Dossou is an expert in tumor immunology, macrophage biology and nanoparticle technology — and a member of the ASBMB Membership Committee.